Pricing Log in Create free account

Immunocore Holdings PLC Sponsored ADR (IMCR) vs Maze Therapeutics, Inc. (MAZE)

Immunocore Holdings PLC Sponsored ADR and Maze Therapeutics, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and Maze Therapeutics, Inc. are of similar size ($1.5B and $1.5B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −4.20%) and the lower return on invested capital (−112.4% vs 0.00%). Across the 13 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 7 and Maze Therapeutics, Inc. on 6.

Valuation

Metric IMCR MAZE Biotechnology median
P/E n/m n/m 8.50
P/S 3.48 n/m 9.71
P/B 3.57 3.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.46 n/m 9.21
Earnings yield (1.22%) (9.15%) (33.15%)
Free cash flow yield (2.75%) (6.58%) (25.50%)

Profitability

Metric IMCR MAZE Biotechnology median
Gross margin 98.90% — 65.16%
Operating margin (5.24%) 0.00% 0.00%
Net margin (4.20%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (4.47%) (37.35%) (56.36%)
Return on assets (1.64%) (31.99%) (48.04%)
Return on invested capital 0.00% (112.36%) 0.00%

Growth

Metric IMCR MAZE Biotechnology median
Revenue growth (TTM) 20.95% — 6.02%
EPS growth (last fiscal year) 30.39% (344.00%) 30.26%
Revenue growth, 5-year CAGR 59.57% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMCR MAZE Biotechnology median
Debt to equity 0.94 0.09 0.00
Current ratio 4.47 18.31 4.72
Net debt to EBITDA 11.19 2.43 0.96

Dividend

Metric IMCR MAZE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMCR MAZE Biotechnology median
Market cap 1.52b 1.53b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack